Trial Profile
Risperidone Augmentation for Treatment-Resistant Aggression in ADHD.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Oct 2009
Price :
$35
*
At a glance
- Drugs Risperidone (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 23 Oct 2009 New trial record